新型抗心律失常药物劳卡尼的评估。
Evaluation of lorcainide, a new anti-arrhythmic agent.
作者信息
Lloyd E A, Workman L J, Commerford P J, Mabin T A
出版信息
S Afr Med J. 1981 Dec 12;60(24):929-31.
PMID:7302777
Abstract
A new anti-arrhythmic agent, lorcainide, has been compared with lignocaine in patients with acute myocardial infarction. Lorcainide has been shown to be as effective as lignocaine in suppressing ventricular ectopy. Lorcainide is unusually free of side-effects and has the great advantage over lignocaine of being effective when given orally.
摘要
一种新型抗心律失常药物劳卡尼，已在急性心肌梗死患者中与利多卡因进行了比较。结果表明，劳卡尼在抑制室性异位心律方面与利多卡因同样有效。劳卡尼的副作用异常少，且与利多卡因相比具有很大的优势，即口服时也有效。
Zotero 插件